ArticleJournal of medicinal chemistry2023

Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.

Wenchao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.